Skip to main content

Dewpoint Therapeutics

Boston, United States

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

$59.1M raised
Sep 2025
Series D

Top Investors

General CatalystMaverick VenturesARCH Venture PartnersSamsara BioCapitalSoftBank Vision Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dewpoint Therapeutics

How much funding has Dewpoint Therapeutics raised?
Dewpoint Therapeutics has raised $59.1M in total funding. The most recent round was Series D. The last funding was announced in September 2025.
Who are Dewpoint Therapeutics's investors?
Dewpoint Therapeutics's investors include General Catalyst, Maverick Ventures, ARCH Venture Partners, Samsara BioCapital, SoftBank Vision Fund.
Where is Dewpoint Therapeutics headquartered?
Dewpoint Therapeutics is headquartered in Boston, United States.
What does Dewpoint Therapeutics do?
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
What stage is Dewpoint Therapeutics at?
Dewpoint Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dewpoint Therapeutics — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/dewpoint-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Dewpoint Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/dewpoint-therapeutics
Wikipedia (cite web)
{{cite web |title=Dewpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dewpoint-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .